Source: Eur Respir J 2006 Oct 01;28(4):695-702
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Phua J., Koay E. S. C., Zhang D., Tai L. K., Boo X. L., Lim K. C., Lim T. K.. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J 2006 Oct 01;28(4):695-702

Member's Comments

No comment yet.

Related content which might interest you: Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections Source: Eur Respir J 2004; 24: 247-250 Year: 2004 Triggering receptor expressed on myeloid cells (TREM)-1 and its soluble form (sTREM-1) as a diagnostic marker of bacterial lung infection Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Soluble forms of CD95 (fas/apo-1), cd38 and CD25 antigens in patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Chronic bronchitis: a risk factor for bronchial infection Source: Eur Respir Monogr 2013; 60: 18-26 Year: 2013 The role of infections in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Pulmonary myeloid dendritic cell numbers, phenotype and response to lipopolysaccharide in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 The TLR5 agonist flagellin prevents bacteria-induced chronic obstructive pulmonary disease exacerbations in mice. Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations? Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001 Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls Source: Annual Congress 2006 - Molecular airway biology Year: 2006 M2 chemokines during acute exacerbations of IPF Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Management of acute exacerbation of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=387 Year: 2006